Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318505514> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2318505514 endingPage "S196" @default.
- W2318505514 startingPage "S196" @default.
- W2318505514 abstract "BackgroundAtrial fibrillation is a known risk factor for thromboembolism. D-dimer levels reflect a pro-thrombogenic state and thus might serve as another marker of warfarin control.AimThis study investigated the correlation of warfarin control marker;PT-INR and pro-thromboembolic marker; D-dimer in patients with atrial fiblliration during oral anticoagulant therapy. Method:This was a single center, retrospective study. Patients with atrial fibrillation (57 males,17 females, mean age 71.8±8.7 years ) treated with warfarin (target PT-INR: 1.5 to 3.0) were included in this investigation based on the medical chart. D-dimer levels and PT-INR were measured, and followed up to June 2014.ResultThe correlation of PT-INR and D-dimer in all patients statistically was found. Espacially the negative relationship between PT-INR and D-dimer in subgroup patients, elderly patients (over 75 years); 28, hypertension patients; 57, patients were statistically found.ConclusionThe correlation of PT-INR and D-dimer in patients of atrial fibrillation was found and thus D-dimer also can serve as surrogate marker of warfarin control. BackgroundAtrial fibrillation is a known risk factor for thromboembolism. D-dimer levels reflect a pro-thrombogenic state and thus might serve as another marker of warfarin control. Atrial fibrillation is a known risk factor for thromboembolism. D-dimer levels reflect a pro-thrombogenic state and thus might serve as another marker of warfarin control. AimThis study investigated the correlation of warfarin control marker;PT-INR and pro-thromboembolic marker; D-dimer in patients with atrial fiblliration during oral anticoagulant therapy. Method:This was a single center, retrospective study. Patients with atrial fibrillation (57 males,17 females, mean age 71.8±8.7 years ) treated with warfarin (target PT-INR: 1.5 to 3.0) were included in this investigation based on the medical chart. D-dimer levels and PT-INR were measured, and followed up to June 2014. This study investigated the correlation of warfarin control marker;PT-INR and pro-thromboembolic marker; D-dimer in patients with atrial fiblliration during oral anticoagulant therapy. Method:This was a single center, retrospective study. Patients with atrial fibrillation (57 males,17 females, mean age 71.8±8.7 years ) treated with warfarin (target PT-INR: 1.5 to 3.0) were included in this investigation based on the medical chart. D-dimer levels and PT-INR were measured, and followed up to June 2014. ResultThe correlation of PT-INR and D-dimer in all patients statistically was found. Espacially the negative relationship between PT-INR and D-dimer in subgroup patients, elderly patients (over 75 years); 28, hypertension patients; 57, patients were statistically found. The correlation of PT-INR and D-dimer in all patients statistically was found. Espacially the negative relationship between PT-INR and D-dimer in subgroup patients, elderly patients (over 75 years); 28, hypertension patients; 57, patients were statistically found. ConclusionThe correlation of PT-INR and D-dimer in patients of atrial fibrillation was found and thus D-dimer also can serve as surrogate marker of warfarin control. The correlation of PT-INR and D-dimer in patients of atrial fibrillation was found and thus D-dimer also can serve as surrogate marker of warfarin control." @default.
- W2318505514 created "2016-06-24" @default.
- W2318505514 creator A5001951570 @default.
- W2318505514 creator A5006347497 @default.
- W2318505514 creator A5007361543 @default.
- W2318505514 creator A5009084626 @default.
- W2318505514 creator A5010549332 @default.
- W2318505514 creator A5031015201 @default.
- W2318505514 creator A5042793561 @default.
- W2318505514 creator A5062657410 @default.
- W2318505514 creator A5085790083 @default.
- W2318505514 date "2014-10-01" @default.
- W2318505514 modified "2023-09-27" @default.
- W2318505514 title "Surrogate Marker of Warfarin Control in Patients with Atrial Fiblliration" @default.
- W2318505514 doi "https://doi.org/10.1016/j.cardfail.2014.07.356" @default.
- W2318505514 hasPublicationYear "2014" @default.
- W2318505514 type Work @default.
- W2318505514 sameAs 2318505514 @default.
- W2318505514 citedByCount "0" @default.
- W2318505514 crossrefType "journal-article" @default.
- W2318505514 hasAuthorship W2318505514A5001951570 @default.
- W2318505514 hasAuthorship W2318505514A5006347497 @default.
- W2318505514 hasAuthorship W2318505514A5007361543 @default.
- W2318505514 hasAuthorship W2318505514A5009084626 @default.
- W2318505514 hasAuthorship W2318505514A5010549332 @default.
- W2318505514 hasAuthorship W2318505514A5031015201 @default.
- W2318505514 hasAuthorship W2318505514A5042793561 @default.
- W2318505514 hasAuthorship W2318505514A5062657410 @default.
- W2318505514 hasAuthorship W2318505514A5085790083 @default.
- W2318505514 hasBestOaLocation W23185055141 @default.
- W2318505514 hasConcept C126322002 @default.
- W2318505514 hasConcept C141341695 @default.
- W2318505514 hasConcept C164705383 @default.
- W2318505514 hasConcept C2776301958 @default.
- W2318505514 hasConcept C2778205648 @default.
- W2318505514 hasConcept C2779161974 @default.
- W2318505514 hasConcept C2779519742 @default.
- W2318505514 hasConcept C2780868729 @default.
- W2318505514 hasConcept C50440223 @default.
- W2318505514 hasConcept C71924100 @default.
- W2318505514 hasConcept C90924648 @default.
- W2318505514 hasConceptScore W2318505514C126322002 @default.
- W2318505514 hasConceptScore W2318505514C141341695 @default.
- W2318505514 hasConceptScore W2318505514C164705383 @default.
- W2318505514 hasConceptScore W2318505514C2776301958 @default.
- W2318505514 hasConceptScore W2318505514C2778205648 @default.
- W2318505514 hasConceptScore W2318505514C2779161974 @default.
- W2318505514 hasConceptScore W2318505514C2779519742 @default.
- W2318505514 hasConceptScore W2318505514C2780868729 @default.
- W2318505514 hasConceptScore W2318505514C50440223 @default.
- W2318505514 hasConceptScore W2318505514C71924100 @default.
- W2318505514 hasConceptScore W2318505514C90924648 @default.
- W2318505514 hasIssue "10" @default.
- W2318505514 hasLocation W23185055141 @default.
- W2318505514 hasOpenAccess W2318505514 @default.
- W2318505514 hasPrimaryLocation W23185055141 @default.
- W2318505514 hasRelatedWork W1973003056 @default.
- W2318505514 hasRelatedWork W1990841128 @default.
- W2318505514 hasRelatedWork W2010333783 @default.
- W2318505514 hasRelatedWork W2112450983 @default.
- W2318505514 hasRelatedWork W2149700114 @default.
- W2318505514 hasRelatedWork W2333911188 @default.
- W2318505514 hasRelatedWork W2355685402 @default.
- W2318505514 hasRelatedWork W2389281378 @default.
- W2318505514 hasRelatedWork W4200343897 @default.
- W2318505514 hasRelatedWork W4317391266 @default.
- W2318505514 hasVolume "20" @default.
- W2318505514 isParatext "false" @default.
- W2318505514 isRetracted "false" @default.
- W2318505514 magId "2318505514" @default.
- W2318505514 workType "article" @default.